Medical Progress Is Real
November 6, 2011 – 12:08 pm | By Anette Breindl | No comments yet
SAN FRANCISCO ‑ I’m enough of a geek that I actually enjoy the details, devil and all, and so I love covering scientific conferences. At the same time, they can be daunting. So much scientific progress is incremental. A case…
Read moreWorld’s Oldest Clinical Trial . . . and Health Economics Not Far Behind
November 4, 2011 – 11:18 am | By Trista Morrison | No comments yet
How old is our clinical trial system?
Read moreWelcome to BioWorld.com 14.0
November 2, 2011 – 11:09 am | By Lynn Yoffee | No comments yet
Raise your hand if you remember receiving BioWorld Today via that curly fax paper. Seems like ages ago, right? We used a “fax blaster” in those early days – more than 20 years ago – to deliver your daily dose…
Read moreReason Free from Passion? That’s Not Biotech
October 27, 2011 – 9:24 am | By Jennifer Boggs | No comments yet
SAN FRANCISCO ‑ At this week’s BIO Investor Forum in San Francisco, there was talk of how the biotech industry has squandered money, paying for infrastructure when it should have been paying only for development and continuing to fund programs…
Read morePfizer’s Greg Simon Talks Change Blindness in Drug Development
October 20, 2011 – 12:04 pm | By Trista Morrison | No comments yet
If you walked up to a desk to sign a consent form for an experiment, and the person behind the desk bent down to file your form, and a different person stood up – someone with a clearly different face,…
Read moreSequencing & Privacy Concerns: Is the Cuckold the Elephant in the Room?
October 14, 2011 – 11:39 am | By Anette Breindl | No comments yet
MONTREAL ‑ At this week’s American Society for Human Genetics annual meeting, where there is a whole genome sequence there is somebody bringing up privacy concerns. Do you really want your genome data to be laid bare? Will it start…
Read moreWhat’s in a Biotech Name? It’s Greek to Me
October 13, 2011 – 2:13 pm | By Jennifer Boggs | 1 comment
OK, you’re a biotech entrepreneur and you’ve found some interesting new technology. You’ve secured some seed funding, found some lab space and filled out all the appropriate paperwork for a business license. All’s that left to incorporate your brand new…
Read moreBiotech Fundraising Plummets in Q3, but Will it Turn on a Dime?
October 10, 2011 – 9:42 am | By Trista Morrison | 1 comment
Biotech companies raised just $2.8 billion in the third quarter of 2011, according to an analysis published in Monday’s BioWorld Insight. That’s a 60 percent drop from the second quarter of this year, and – just in case you thought…
Read moreDrug Shortages? We Ain’t Seen Nothin’ Yet
October 6, 2011 – 11:18 am | By Mari Serebrov | No comments yet
You think the drug shortage is a devil now
Read moreRalph Steinman Remembered: A Glimpse of Humility
October 3, 2011 – 11:10 am | By Anette Breindl | No comments yet
It seems likely that this year’s Nobel Prize for physiology or medicine will be remembered by many people who normally forget about it before the physics prize is even announced. One of the three prize winners, Ralph Steinman, passed away…
Read more
Join the Conversation